Sign in
4

Changes in Ownership

PALISADE BIO, INC. Filed Acc 0001209191-22-021051

Chief Financial Officer bought 7,500 shares at $1.09 ($8,174)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Finley John David Chief Financial Officer 2022-03-24 Purchase +7,500 $1.09 $8,174 21,896 D: show line 1 in the form
Open-market purchases · 7,500 sh · avg $1.09 · $8,174
Loading xslF345X03/doc4.xml…